Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03077594 · ClinicalTrials.gov registry record

Characterization of the Neo-squamous Epithelial Barrier

A clinical trial of Barretts Esophagus With Dysplasia, sponsored by Mayo Clinic.

Completed
Registry status
53
Enrollment target
2
Study locations

NCT03077594 is a study of Barretts Esophagus With Dysplasia that has completed, run by Mayo Clinic. The registered enrollment target is 53 participants, below the 700-participant average among 5 other Barretts Esophagus With Dysplasia trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03077594, a study of Barretts Esophagus With Dysplasia, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
53 participants
Enrollment target
2
Study locations

Study Summary

To prospectively assess the functional aspects of the the esophageal squamous epithelial barrier and correlate this with tissue inflammation and intercellular space dilation in patients who have successfully completed endoscopic radiofrequency ablation versus balloon cryotherapy for Barrett's Esophagus related metaplasia.

Interventions

  • DEVICE Mucosal Impedance
  • OTHER Research Biopsies
  • DEVICE Volumetric Laser Endomicroscopy

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2016-09-26
Est. Completion 2022-06-29

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03077594

The ClinicalTrials.gov registry entry for NCT03077594 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 700-participant average among 5 other Barretts Esophagus With Dysplasia trials with a reported enrollment target (92% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Barretts Esophagus With Dysplasia appearing as the primary indexed condition, and to 3 interventions - of which Mucosal Impedance is the first listed.

NCT03077594 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, New York.

Frequently Asked Questions

What is clinical trial NCT03077594 about?

NCT03077594 is a clinical study titled "Characterization of the Neo-squamous Epithelial Barrier". To prospectively assess the functional aspects of the the esophageal squamous epithelial barrier and correlate this with tissue inflammation and intercellular space dilation in patients who have successfully completed endoscopic radiofrequency ablation versus balloon cryotherapy for Barrett's Esopha...

What is the current status of trial NCT03077594?

This trial is currently completed. The enrollment target is 53 participants. The study started on 2016-09-26. Estimated completion is 2022-06-29.

What conditions does trial NCT03077594 study?

This clinical trial studies the following conditions: Barretts Esophagus With Dysplasia.

What interventions are being tested in trial NCT03077594?

The interventions under investigation include: Mucosal Impedance (DEVICE), Research Biopsies (OTHER), Volumetric Laser Endomicroscopy (DEVICE).

Who is sponsoring clinical trial NCT03077594?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03077594 being conducted?

This trial has 2 study locations across Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Barretts Esophagus With Dysplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.